Filter by: Subject

Filter by: Subject

Results Per Page:

Malaria (23)
South Africa (SA) (15)
Plasmodium falciparum (12)
SDG-03: Good health and well-being (9)
Indoor residual spraying (IRS) (6)
Plasmodium (6)
Antimalarials (5)
Gametocyte (5)
Insecticides (5)
Mosquitoes (5)
Vector control (5)
Neglected tropical diseases (NTDs) (4)
Transmission-blocking (4)
Aedes (3)
Africa (3)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Dichlorodiphenyltrichloroethane (DDT) (3)
Elimination (3)
Gametocytes (3)
Kenya (3)
Limpopo Province, South Africa (3)
Machine learning (3)
Malaria prevention (3)
Surveillance (3)
Venda health examination of mothers, babies and their environment (VHEMBE) (3)
Africa region (2)
African horse sickness (AHS) (2)
Antiplasmodial (2)
Attenuated total reflection (ATR) (2)
Behavioural change (2)
Benzimidazole (2)
Controlled release (2)
Core functions (2)
Culex (2)
Dengue (2)
Dichlorodiphenyldichloroethylene (DDE) (2)
Disease prevention (2)
Disease vectors (2)
Drug discovery (2)
Efficacy (2)
Endocrine disrupting chemicals (EDCs) (2)
Epigenetics (2)
Healthcare workers (HCWs) (2)
Heterocycles (2)
Implementation (2)
Inhibitors (2)
Intervention (2)
Knowledge retention (2)
Malaria education (2)
Malaria elimination (2)
Mosquito repellents (2)
Music education (2)
Parasites (2)
Polyethylene (2)
Polymerase chain reaction (PCR) (2)
Preventive chemotherapy neglected tropical diseases (PC-NTDs) (2)
Preventive chemotherapy-targeted neglected tropical diseases (PC-NTDs) (2)
Residual transmission (2)
Resistance (2)
Scanning electron microscopy (SEM) (2)
Support functions (2)
Vector (2)
20E-signaling (1)
Acceptability (1)
Acquired immunity (1)
Acute febrile illness (1)
Adenosine triphosphate (ATP) (1)
Adiposity (1)
Adsorption (1)
Aedes species (1)
African malaria vector (1)
African region (1)
Allergies (1)
Aloe marlothii (1)
Alphaviruses (1)
Amides (1)
Amino-artemisinins (1)
Androgenic (1)
Anopheles (1)
Anopheles arabiensis (1)
Anthraquinones (1)
Antimalarial drugs (1)
Antiparasitic agents (1)
Antiplasmodium (1)
Artemether–lumefantrine (1)
Artemisinin resistance (1)
Artemisinin-based combination therapies (ACTs) (1)
Artemisinin-based combination therapy (ACT) (1)
Artemisinins (1)
Artificial light at night (ALAN) (1)
Asexual blood stage (ABS) (1)
Astemizole (1)
Asthma (1)
Asymptomatic carriage (1)
BDM auctions (1)
Becker-DeGroot-Marschak (BDM) (1)
Bioassays (1)
Biomarker (1)
Bisphenol A (BPA) (1)